-
Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosis
de Wit, K., van Doorn, D. J., Mol, B., van Vught, L. A., Nevens, F., Beuers, U., Ponsioen, C. Y., Teunissen, C. E. & Takkenberg, R. B., 1 May 2024, In: Annals of hepatology. 29, 3, 101496.Research output: Contribution to journal › Article › Academic › peer-review
-
Can liver stiffness measurement accurately predict disease progression and clinical outcome in patients with metabolic dysfunction-associated steatotic liver disease and bridging fibrosis or cirrhosis?
van Doorn, D. J., Holleboom, A. G., Takkenberg, R. B., Verheij, J. & Lantinga, M. A., 1 Dec 2023, In: Hepatobiliary surgery and nutrition. 12, 6, p. 912-915 4 p.Research output: Contribution to journal › Article › Academic
-
Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy
on behalf of the Photodynamic Therapy Study Group, 2022, Methods in Molecular Biology. Humana Press Inc., Vol. 2451. p. 285-403 119 p. (Methods in Molecular Biology; vol. 2451).Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review
- All publications
